CLEVELAND, OH — The age/sex/gene-expression score (ASGES) test known as Corus CAD (CardioDx) appears easy to incorporate and effective in excluding obstructive coronary artery disease (CAD) in ...
USD/CAD is currently trying to settle above the resistance at 1.2915 while the U.S. dollar is gaining some ground against a broad basket of currencies. The U.S. Dollar Index managed to settle above ...
Coverage of Blood-Based Test Has Potential to Improve Quality of Care and Lower Costs of Diagnosis of Obstructive Coronary Artery Disease Beyond Traditional Methods PALO ALTO, Calif. – CardioDx, Inc., ...
Please provide your email address to receive an email when new articles are posted on . CHICAGO — In stable symptomatic patients with suspected CAD, a precision testing strategy was linked to a 70% ...
Cardiovascular genomic's specialist Cardiodx Inc.'s test to detect obstructive coronary artery disease (CAD) received long-term validation from a study published in this month's American Heart Journal ...
USD/CAD moves little after two days of losses, trading around 1.3990 during the early European hours on Thursday. The ...
PALO ALTO, CA--(Marketwired - Mar 10, 2014) - CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, today announced the publication of the IMPACT-PCP (Investigation ...
USD/CAD is currently trying to settle below the support at 1.2530 while the U.S. dollar is losing ground against a broad basket of currencies. The U.S. Dollar Index managed to get below the support ...
CHICAGO — In stable symptomatic patients with suspected CAD, a precision testing strategy was linked to a 70% reduction in death, MI or catheterization without obstructive CAD at 1 year compared with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback